The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. [electronic resource]

By:

Luketic, V A

Contributor(s):

Sanyal, A J

Producer: 19940912Description: 74-9 p. digitalISSN:

1065-2477

Subject(s):

Alagille Syndrome -- drug therapy
Biliary Atresia -- drug therapy
Cholangitis, Sclerosing -- drug therapy
Cholestasis -- drug therapy
Chronic Disease
Cystic Fibrosis -- drug therapy
Graft vs Host Disease -- drug therapy
Humans
Liver Cirrhosis, Biliary -- drug therapy
Liver Diseases -- drug therapy
Ursodeoxycholic Acid -- therapeutic use

In: The Gastroenterologist vol. 2

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

Browse results Close

Back to results

1 [From clinical medicine to experimentation: cerebral vascular accidents, a new field for the use of a coronarodilator, carbochromene].
by Giovannoni, L
2 Highly fluorescent protein labeling using dendritic peptide derivatives.
by Giovannoni, L
3 Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.
by Giovannoni, L
4 Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis.
by Viti, F
5 The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity.
by Hemmerle, T
6 Open visiting policies in Intensive Care Units may not affect consent to organ donation.
by Bambi, S
7 Prevalence of genetic risk factors for coronary artery disease in Corsica island (France).
by Falchi, A
8 A strategy for the isolation of catalytic activities from repertoires of enzymes displayed on phage.
by Demartis, S
9 Cholesteryl ester transfer protein gene polymorphisms are associated with coronary artery disease in Corsican population (France).
by Falchi, A
10 Experimental study of argon laser-induced microthrombosis during PGI2 infusion.
by Boncinelli, S
11 A functional circadian clock is required for proper insulin secretion by human pancreatic islet cells.
by Saini, C
12 Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.
by Spitaleri, G
13 Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis.
by Dietrich, T
14 Autonomous and self-sustained circadian oscillators displayed in human islet cells.
by Pulimeno, P
15 A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.
by Galeazzi, M

The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.

APA

Luketic V. A., Sanyal A. J., . (19940912). The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. : The Gastroenterologist.

Chicago

Luketic V A, Sanyal A J, . 19940912. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. : The Gastroenterologist.

Harvard

Luketic V. A., Sanyal A. J., . (19940912). The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. : The Gastroenterologist.

MLA

Luketic V A, Sanyal A J, . The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. : The Gastroenterologist. 19940912.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC